RE.DOCTOR Digital Biomarker of Diabetes - RE.DOCTOR

Scan TechnologyRE.DOCTOR Digital Biomarker of Diabetes

RE.DOCTOR Digital Biomarker of Diabetes

The global burden of diabetes is rapidly increasing, and expected to top 693 million by 2045. The subtle onset of type 2 diabetes delays diagnosis and increases morbidity.
Given the multifactorial vascular effects of diabetes, RE.DOCTOR has developed a smartphone-based photoplethysmography (PPG) tool that provides a widely-accessible digital biomarker for diabetes.
Research and testing partners are needed to fully exploit the technology. Learn more at